Tizetatug rezetecan
Tizetatug rezetecan (SHR-A1921) is an Antibody-drug Conjugate (ADC) composed of antibody Tizetatug and MC-Gly-Gly-Phe-Gly- (R) -Cyclopropane-Exatecan (HY-148668). Tizetatug rezetecan can be used for the research of cancer[1].
Product Specifications
CAS Number
2938864-88-9
Product Name Alternative
SHR-A1921
UNSPSC
12352005
Target
Antibody-Drug Conjugates (ADCs)
Related Pathways
Antibody-drug Conjugate/ADC Related
Field of Research
Cancer
Smiles
[Tizetatugrezetecan]
Shipping Conditions
Room temperature
Scientific Category
ADC Related
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog